Author ORCID Identifier
Joshua Keefer - 0000-0002-2337-4588
Keywords
Survival, Metastatic Pancreatic Cancer, Metastasis, Folfirinox
Disciplines
Medicine and Health Sciences
Abstract
Pancreatic adenocarcinoma is an aggressive cancer with poor outcomes regardless of resection and treatment. The 5-year survival rate is less than 10%. Even with proper resection of the primary tumor, there remains a high likelihood of recurrence within 20 months. This is the case of a patient who was diagnosed with pancreatic adenocarcinoma 7 years ago. This patient underwent resection of the primary tumor along with chemotherapy and radiation. Two recurrences, located in the lung, have both been resected. This case highlights the importance of prompt resection and regular surveillance to monitor for additional metastases.
Recommended Citation
Keefer J, Cooper M, Pacioles T, Arrington A.
Long-term Survival After Metastatic Pancreatic Cancer.
Marshall J Med.
2024;
10(4)
DOI: https://doi.org/10.33470/2379-9536.1404.
